Chimerix Inc. (NASDAQ: CMRX) Stock Information | RedChip

Chimerix Inc. (NASDAQ: CMRX)


$2.9900
N/A ( -0.43% ) 45.4K

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Market Data


Open


$2.9900

Previous close


$2.9900

Volume


45.4K

Market cap


$268.91M

Day range


$2.9850 - $3.1490

52 week range


$0.7500 - $3.3900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 53 Dec 10, 2024
8-k 8K-related 14 Nov 14, 2024
8-k 8K-related 51 Nov 07, 2024
10-q Quarterly Reports 53 Nov 07, 2024
4 Insider transactions 1 Oct 30, 2024
10-q Quarterly Reports 54 Aug 13, 2024
8-k 8K-related 51 Aug 13, 2024
4 Insider transactions 1 Aug 09, 2024
8-k 8K-related 13 Jul 03, 2024
8-k 8K-related 13 Jun 21, 2024

Latest News